Literature DB >> 9561138

Cyclooxygenase-2 in the spinal cord: localization and regulation after a peripheral inflammatory stimulus.

M Goppelt-Struebe1, F Beiche.   

Abstract

Prostaglandins are known as mediators in spinal nociceptive processing after peripheral inflammation. Cyclooxygenase isozymes Cox-1 and Cox-2 as enzymes essential for prostaglandin biosynthesis were therefore investigated in rat spinal cord. mRNA and protein of both enzymes was detected in cervical and lumbar sections of the spinal cord of normal animals. Enzyme activity of Cox-1 and Cox-2 could be determined by the use of specific inhibitors. Cox-2-immunoreactivity (IR) was found in the spinal cord of untreated rats in neurons of laminae II-III, motoneurons of lamina IX and in glial cells. Most prominent staining was observed in the nuclear envelope. Under an acute peripheral inflammatory stimulus a transient 2-fold increase in Cox-2 mRNA was noticed bilaterally in the lumbar spinal cord by reverse transcription-polymerase chain reaction. This increase was reflected on a smaller scale at protein levels in Western blot analysis of spinal membrane preparations. In the chronic state of adjuvant-induced arthritis, Cox-2 levels were raised again significantly. Cox-2 might therefore be regarded as the Cox isozyme responsible for increased spinal prostanoid release in nociceptive processing under peripheral stimulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9561138     DOI: 10.1007/978-1-4899-1810-9_45

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

1.  Chapter 9 The dorsal horn and hyperalgesia.

Authors:  Karin N Westlund
Journal:  Handb Clin Neurol       Date:  2006

2.  Management of Inflammatory Pain with Selective COX-2 Inhibitors: Promises and Facts.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

Review 3.  Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke.

Authors:  Cameron Rink; Savita Khanna
Journal:  Antioxid Redox Signal       Date:  2010-12-04       Impact factor: 8.401

4.  In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin.

Authors:  D M Dirig; T L Yaksh
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

5.  Spinal prostaglandins are involved in the development but not the maintenance of inflammation-induced spinal hyperexcitability.

Authors:  E Vasquez; K J Bär; A Ebersberger; B Klein; H Vanegas; H G Schaible
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

6.  Cyclooxygenase-1 and -2 in brains of patients who died with sporadic Creutzfeldt-Jakob disease.

Authors:  Martin H Deininger; Kubrom Bekure-Nemariam; Katrin Trautmann; Matthias Morgalla; Richard Meyermann; Hermann J Schluesener
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

7.  Vitamin A active metabolite, all-trans retinoic acid, induces spinal cord sensitization. I. Effects after oral administration.

Authors:  E A Romero-Sandoval; C Molina; M Alique; V Moreno-Manzano; F J Lucio; J F Herrero
Journal:  Br J Pharmacol       Date:  2006-07-17       Impact factor: 8.739

8.  Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia.

Authors:  Joseph R Ghilardi; Camilla I Svensson; Scott D Rogers; Tony L Yaksh; Patrick W Mantyh
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

9.  COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord.

Authors:  Yiangos Yiangou; Paul Facer; Pascal Durrenberger; Iain P Chessell; Alan Naylor; Chas Bountra; Richard R Banati; Praveen Anand
Journal:  BMC Neurol       Date:  2006-03-02       Impact factor: 2.474

Review 10.  NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data.

Authors:  Arpad Pardutz; Jean Schoenen
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.